Fidelity Select Medical Tech and Devcs holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Fidelity Select Medical Technology and Devices Portfolio FSMEX
- NAV / 1-Day Return 48.10 / −0.19 %
- Total Assets 3.1B
-
Adj. Expense Ratio
0.620%
- Expense Ratio 0.620%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Mid Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 54%
USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 4:51 AM GMT+0
Morningstar’s Analysis FSMEX
Will FSMEX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 63.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Danaher Corp | 15.09 | 449M | Healthcare |
Thermo Fisher Scientific Inc | 14.06 | 419M | Healthcare |
Intuitive Surgical Inc | 7.45 | 222M | Healthcare |
Boston Scientific Corp | 5.11 | 152M | Healthcare |
Edwards Lifesciences Corp | 4.21 | 125M | Healthcare |
Stryker Corp | 4.18 | 124M | Healthcare |
Abbott Laboratories | 3.85 | 115M | Healthcare |
Waters Corp | 3.27 | 97M | Healthcare |
Agilent Technologies Inc | 3.21 | 96M | Healthcare |
West Pharmaceutical Services Inc | 3.09 | 92M | Healthcare |
United States